fbpx

Double Chin Begone: Kybella

Kybella, A Fat-Destroying Injectable Drug, Approved By The FDA

Oh, the pesky double chin! Caused by aging, genetics, weight gain — or any combination of these factors – is often resistant to diet and exercise. The double chin has also historically been an undertreated facial aesthetic condition, despite 2014 survey results from the American Society for Dermatologic Surgery (ASDC), which indicate that over two-thirds of consumers are bothered by their double chins.

Double Chin
Just in time for the holidays Epi Center Medspa is proud to offer KYBELLA™ the latest treatment for this “aesthetic condition.” The Food and Drug Administration approved Kybella (deoxycholic acid) for moderate-to-severe fat below the chin. Kybella, a drug that is injected directly into the chin area where it destroys fat cells.

“Using Kybella for the treatment of fat outside of the submental area is not approved and is not recommended,” the FDA warned in its announcement. Kybella is identical to the deoxycholic acid that is produced in the body to help absorb fats.

Learn more about KYBELLA and other Epi Center MedSpa treatments and products by visiting us at www.skinrejuv.com, 450 Sutter St. Suite 800, San Francisco, CA 94108 or call us to book your next appointment at 415.362.4754.

Consultations free, results priceless.

Menu